Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3Phase 1/2 2Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 314Carcinoma, Non-Small-Cell Lung 161Breast Neoplasms 125Neoplasm Metastasis 105Melanoma 94Leukemia, Myeloid, Acute 80Lymphoma 79Multiple Myeloma 74Colorectal Neoplasms 73Ovarian Neoplasms 69Lymphoma, Non-Hodgkin 63Recurrence 58Prostatic Neoplasms 55Pancreatic Neoplasms 51Lung Neoplasms 49Glioblastoma 39Carcinoma, Renal Cell 39Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Lymphoma, Large B-Cell, Diffuse 37Leukemia, Lymphocytic, Chronic, B-Cell 37Leukemia 36Advanced Solid Tumors 36Myelodysplastic Syndromes 35Triple Negative Breast Neoplasms 33Head and Neck Neoplasms 33Sarcoma 31Brain Neoplasms 31Urinary Bladder Neoplasms 30Stomach Neoplasms 30Lymphoma, Follicular 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Has results × Pathologic Complete Response × Clear all
NCT00725283 2018-08-07

Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)

GlaxoSmithKline

Phase 1 Completed
34 enrolled 10 charts
Other hematologic neoplasm

Pathologic Complete Response, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡